 Connection
Dulcy Wolverton to Breast Neoplasms
This is a "connection" page, showing publications Dulcy Wolverton has written about Breast Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.477 |
|
|
|
-
Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, Chikarmane S, Conant EF, Eghtedari M, Flanagan MR, Hawley J, Helvie M, Hodgkiss L, Hoyt TL, Ivanovich J, Jochelson MS, Kulkarni S, Lancaster RB, Mauer C, Maxwell J, Patel BK, Pearlman M, Philpotts L, Plecha D, Plichta JK, Shakeri S, Smith ML, Streibert CL, Strigel RM, Tumyan L, Winkler NS, Wolverton DE, Bergman MA, Kumar R, Stehman K. NCCN Guidelines? Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Netw. 2023 09; 21(9):900-909.
Score: 0.101
-
Onishi N, Li W, Newitt DC, Harnish RJ, Strand F, Nguyen AA, Arasu VA, Gibbs J, Jones EF, Wilmes LJ, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard S, Umphrey HR, Nelson MT, Church AL, Bolan PJ, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez Paniagua D, Hardesty L, Brandt KR, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane E, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica LA, Niell B, Drukteinis J, Newell MS, Giurescu ME, Berman E, Lehman CD, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau SH, Chenevert T, Yau C, DeMichele A, Berry DA, Esserman LJ, Hylton NM. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
Score: 0.088
-
Kovar A, Bronsert M, Jaiswal K, Murphy C, Wolverton D, Ahrendt G, Tevis S. The Waiting Game: How Long Are Breast Cancer Patients Waiting for Definitive Diagnosis? Ann Surg Oncol. 2020 Oct; 27(10):3641-3649.
Score: 0.080
-
Meyerson AF, Lessing JN, Itakura K, Hylton NM, Wolverton DE, Joe BN, Esserman LJ, Hwang ES. Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast. 2011 Dec; 20(6):529-33.
Score: 0.044
-
Esserman LJ, Kumar AS, Herrera AF, Leung J, Au A, Chen YY, Moore DH, Chen DF, Hellawell J, Wolverton D, Hwang ES, Hylton NM. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol. 2006 Oct 01; 24(28):4603-10.
Score: 0.031
-
Jacobs TW, Chen YY, Guinee DG, Holden JA, Cha I, Bauermeister DE, Hashimoto B, Wolverton D, Hartzog G. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am J Clin Pathol. 2005 Sep; 124(3):342-54.
Score: 0.029
-
Shah N, Gibbs J, Wolverton D, Cerussi A, Hylton N, Tromberg BJ. Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt. 2005 Sep-Oct; 10(5):051503.
Score: 0.029
-
Esserman L, Wolverton D, Hylton N. Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocr Relat Cancer. 2002 Jun; 9(2):141-53.
Score: 0.023
-
Esserman LJ, Wolverton D, Hylton N. Integration of breast imaging into cancer management. Curr Oncol Rep. 2000 Nov; 2(6):572-81.
Score: 0.021
-
Wolverton DE, Sickles EA. Clinical outcome of doubtful mammographic findings. AJR Am J Roentgenol. 1996 Oct; 167(4):1041-5.
Score: 0.016
-
Jiang Y, Nishikawa RM, Wolverton DE, Metz CE, Giger ML, Schmidt RA, Vyborny CJ, Doi K. Malignant and benign clustered microcalcifications: automated feature analysis and classification. Radiology. 1996 Mar; 198(3):671-8.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|